http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5785374-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfc033f059d282fcd915bc8be2ae53f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 1980-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54af6e8db59d6e04a3ed0c29582622ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c01ebfde04f3050922528eb2d4777f7
publicationDate 1982-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5785374-A
titleOfInvention 5-fluorouracil derivative and its preparation
abstract NEW MATERIAL:A 5-fluorouracil derivative expressed by formula I(R is 5- ethylenedioxyhexyl, 5-oxohexyl or 5-hydroxyhexyl). n EXAMPLE: 1-(5-Ethylene dioxyhexylcarbamoyl)-5-fluorouracil. n USE: A carcinostatic agent. n PROCESS: 5-Oxocapronitrile is reacted with ethylene glycol in the presence of an acidic catalyst, e.g. p-toluenesulfonic acid, to form 5-ethylenedioxycapronitrile expressed by formula II, which is then catalytically reduced with lithium aluminum hydride or Raney nickel to give 5-ethylenedioxyhexylamine. The resultant compound is then reacted with 1-chlorocarbonyl-5-fluorouracil to afford the compound expressed by formula I(R is 5-ethylenedioxyhexyl). n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1980-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5581865-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5277073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5663966-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5373572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S53130679-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67877182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70554217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413540028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451400856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428268258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226666299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236488165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234746585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234949341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70552634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14451336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236482342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420177756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19005189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415775934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233475763

Total number of triples: 48.